Article
Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.
American journal of men's health - 1 Jan 2000
Effah Clement Yaw, Wang Ling, Agboyibor Clement, Drokow Emmanuel Kwateng, Yu Songcheng, Wang Wei, Wu Yongjun
Abstract excerpt
Gene polymorphism is one of the few factors that increases the risk of prostate cancer. T to C substitution in the 5' promoter region of the CYP17 gene is hypothesized to increase the rate of gene transcription, increase androgen production, and thereby increase the risk of prostate cancer. Nevertheless, the inconsistencies originating from studies on CYP17 polymorphism and prostate cancer prompted this...
Topics
Join the communities discussing this publication.
